PKM2 and ACVR 1C are prognostic markers for poor prognosis of gallbladder cancer

Suppression of activin A signals inhibits growth of malignant pleural mesothelioma cells

(2012) M A Hoda et al.   BRITISH JOURNAL OF CANCER

Squamous cell and adenosquamous carcinomas of the gallbladder: clinicopathological analysis of 34 cases identified in 606 carcinomas

(2011) Juan C Roa et al.   MODERN PATHOLOGY

Identification of PEG10 and TSG101 as Carcinogenesis, Progression, and Poor-Prognosis Related Biomarkers for Gallbladder Adenocarcinoma

(2011) Dong-cai Liu et al.   PATHOLOGY & ONCOLOGY RESEARCH

Management of Gallbladder Cancer

(2010) Shiva Jayaraman et al.   GASTROENTEROLOGY CLINICS OF NORTH AMERICA

Pyruvate kinase type M2: A key regulator of the metabolic budget system in tumor cells

(2010) Sybille Mazurek   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

TGF-ß signaling, tumor microenvironment and tumor progression: the butterfly effect

(2009) Amit Joshi   Frontiers in Bioscience-Landmark

Signal Transduction Pathway through Activin Receptors as a Therapeutic Target of Musculoskeletal Diseases and Cancer

(2008) Kunihiro TSUCHIDA et al.   ENDOCRINE JOURNAL

Isotype-specific inhibitors of the glycolytic key regulator pyruvate kinase subtype M2 moderately decelerate tumor cell proliferation

(2008) Gilles A. Spoden et al.   INTERNATIONAL JOURNAL OF CANCER